NCT00002915View on ClinicalTrials.gov

Penclomedine in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1996

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

penclomedine

Trial Locations (1)

21287

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00002915 - Penclomedine in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter